{"doc_id": "si-2023-0584-reg-1", "parent_doc_id": "si-2023-0584", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 584 of 2023", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2023, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 7) Regulations 2023. \n\n(2) The collective citation “the Medicinal Products (Prescription and \n\nControl of Supply) Regulations 2003 to 2023” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 7) regulation 2023 (2) collective citation medicinal product (prescription control supply) regulation 2003 2023 includes regulation", "start_char": 618, "end_char": 908, "source_path": "downloads\\2023\\2023_0584.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7067f57845d5baf1ef6c39b698b47076551d2a768c3a2d5c59b9391b5f493770", "cross_refs": []}
{"doc_id": "si-2023-0584-reg-2", "parent_doc_id": "si-2023-0584", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 584 of 2023", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2023, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Medicinal Products (Prescription and \nControl of Supply) Regulations 2003 (S.I. No. 540 of 2003); \n\n“Regulations of 2023” means the Medicinal Products (Prescription and Control \nof Supply) (Amendment) (No. 6) Regulations 2023 (S.I. No. 451 of 2023).", "text_norm": "2 regulations-- principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) regulation 2023 mean medicinal product (prescription control supply) (amendment) (no 6) regulation 2023 (s.i no 451 2023)", "start_char": 908, "end_char": 1223, "source_path": "downloads\\2023\\2023_0584.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7067f57845d5baf1ef6c39b698b47076551d2a768c3a2d5c59b9391b5f493770", "cross_refs": []}
{"doc_id": "si-2023-0584-reg-3", "parent_doc_id": "si-2023-0584", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 584 of 2023", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2023, "heading": "3. The Eighth Schedule (as amended by Regulation 3 of the Regulations", "text_raw": "3. The Eighth Schedule (as amended by Regulation 3 of the Regulations \nof 2023) to the Principal Regulations is amended by inserting the following \nentry: \n\n“ \n\nMedicinal \nProduct \n\nof \n\nRoute \nadministratio\nn \n\nForm \nand \npresentation \nof product \nadministere\nd \n\nIndication \nfor which the \nmedicinal \nproduct may \nbe \nadministered \n\nDosage \nand \nconditions of \nadministratio\nn \n\nof \n\nPlace \nadministratio\nn \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nColumn 5 \n\nColumn 6 \n\nNuvaxovid \n\nXBB.1.5 \ndispersion \nfor injection \nCOVID-19 \nVaccine \n(recombinant\n, adjuvanted) \n\nDispersion \nfor injection \n\nIntramuscular \ninjection \n\nThe \ndispersion \nis colourless \nto \nslightly \nyellow, \nclear \nmildly \nopalescent \n\nto \n\nby \n\nActive \nimmunisatio\nn to prevent \nCOVID-19 \ncaused \nSARS-CoV2 \nindividuals \n12 years of \nand \nage \nolder. \n\nin \n\nIn accordance \nwith \nthe \nsummary of \nproduct \ncharacteristic\nof \ns \nproduct \nadministered \nand/or \nrelevant \nnational \nguidelines \n\nthe \n\nAny suitable \nand \nappropriate \nplace, having \nregard \nto \npublic \nconvenience \nand the need \nto protect the \nand \nhealth \nsafety of the \nand \npublic \n\nNotice of the making of this Statutory Instrument was published in \n\"Iris Oifigiúil\" of 1st December, 2023. \n\n \n \n \n \n \n \n \n \n \n\f(pH 7.2) \n\n”. \n\n[584] 3 \n\nsafely \nadminister \nthe product. \n\nissued by the \nNational \nImmunisation \nAdvisory \nCommittee.", "text_norm": "3 eighth schedule (as amended regulation 3 regulation 2023) principal regulation amended inserting following entry medicinal product route administratio n form presentation product administere indication medicinal product may administered dosage condition administratio n place administratio n column 1 column 2 column 3 column 4 column 5 column 6 nuvaxovid xbb.1.5 dispersion injection covid-19 vaccine (recombinant adjuvanted) dispersion injection intramuscular injection dispersion colourless slightly yellow clear mildly opalescent active immunisatio n prevent covid-19 caused sars-cov2 individual 12 year age older accordance summary product characteristic product administered relevant national guideline suitable appropriate place regard public convenience need protect health safety public notice making statutory instrument published iris oifigiuil 1st december 2023 (ph 7.2)  584 3 safely administer product issued national immunisation advisory committee", "start_char": 1223, "end_char": 2600, "source_path": "downloads\\2023\\2023_0584.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7067f57845d5baf1ef6c39b698b47076551d2a768c3a2d5c59b9391b5f493770", "cross_refs": []}
{"doc_id": "si-2023-0584-reg-4", "parent_doc_id": "si-2023-0584", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 584 of 2023", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2023, "heading": "4. The Twelfth Schedule (as amended by Regulation 4 of the Regulations", "text_raw": "4. The Twelfth Schedule (as amended by Regulation 4 of the Regulations \nof 2023) to the Principal Regulations is amended by inserting the following \nentry: \n\n“ \n\nMedicinal \nproduct \n\nof \nRoute \nadministration \n\nand \nForm \npresentation \nof \nproduct \nadministered \n\nfor \nIndication \nwhich \nthe \nmedicinal product \nmay \nbe \nadministered \n\nDosage \nconditions \nadministration \n\nand \nof \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nColumn 5 \n\nof \nproduct \n\nIn accordance with \nsummary of \nthe \nproduct \ncharacteristics \nthe \nadministered \nand/or \nrelevant \nnational guidelines \nissued \nthe \nNational \nImmunisation \nAdvisory \nCommittee. \n\nby \n\nDispersion \nfor injection \n\nIntramuscular \ninjection \n\nThe \ndispersion is \ncolourless to \nslightly \nyellow, clear \nmildly \nto \nopalescent \n(pH 7.2) \n\nActive \nto \nimmunisation \nprevent COVIDby \n19 \ncaused \nin \nSARS-CoV-2 \n12 \nindividuals \nyears of age and \nolder. \n\nNuvaxovid \n\nXBB.1.5 \ndispersion for \ninjection \nCOVID-19 \nVaccine \n\n(recombinant, \nadjuvanted) \n\n”. \n\nGIVEN under my Official Seal, \n\n29 November, 2023. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n\f4 [584]", "text_norm": "4 twelfth schedule (as amended regulation 4 regulation 2023) principal regulation amended inserting following entry medicinal product route administration form presentation product administered indication medicinal product may administered dosage condition administration column 1 column 2 column 3 column 4 column 5 product accordance summary product characteristic administered relevant national guideline issued national immunisation advisory committee dispersion injection intramuscular injection dispersion colourless slightly yellow clear mildly opalescent (ph 7.2) active immunisation prevent covidby 19 caused sars-cov-2 12 individual year age older nuvaxovid xbb.1.5 dispersion injection covid-19 vaccine (recombinant adjuvanted)  given official seal 29 november 2023 stephen donnelly minister health 4 584", "start_char": 2600, "end_char": 3737, "source_path": "downloads\\2023\\2023_0584.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7067f57845d5baf1ef6c39b698b47076551d2a768c3a2d5c59b9391b5f493770", "cross_refs": []}
{"doc_id": "si-2023-0584-explanatory-note", "parent_doc_id": "si-2023-0584", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 584 of 2023", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2023, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to update the relevant schedules in relation \nto the COVID-19 vaccines to include the Nuvaxovid XBB.1.5 COVID-19 \nvaccine. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 7) Regulations 2023. \n\n \n \n \n \n \n \n \n\f[584] 5 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-507) 75. 11/23. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation update relevant schedule relation covid-19 vaccine include nuvaxovid xbb.1.5 covid-19 vaccine regulation may cited medicinal product (prescription control supply) (amendment) (no 7) regulation 2023 584 5 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-507) 75 11 23 propylon", "start_char": 3737, "end_char": 4762, "source_path": "downloads\\2023\\2023_0584.pdf", "extraction_method": "pdfminer", "checksum": "sha256:7067f57845d5baf1ef6c39b698b47076551d2a768c3a2d5c59b9391b5f493770", "cross_refs": []}
